RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING INDINAVIR ALONE, ZIDOVUDINE ALONE AND INDINAVIR PLUS ZIDOVUDINE IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED INDIVIDUALS WITH CD4 CELL COUNTS BETWEEN 50 AND 250/MM3

Ano: 2000 | Volume: 42 | Número: 1

Autores: D. S. Lewi, J. M. Suleiman, D. E. Uip, D. E. Uip, R. J. Pedro, R. A. Souza, G. S. Suleiman, C. Accetturi, O. M. Leite, W. B. Abreu, A. O. Kalichman, J. P. P. Moraes-filho, E. F. Motti, M. L. C. Pecoraro, M. R. Makurath, M. L. Nessly, R. Y. Leavitt

Palavras-chave: randomized study, double blind clinical trial, hiv, aids, protease inhibitors, indinavir, zidovudine, disease progression, therapy, clinical endpoint

Resumo Inglês:

Treatment with indinavir has been shown to result in marked decreases in viral load and increases in